TCM
Tang Capital Management Portfolio holdings
AUM
$1.98B
This Quarter Return
+47.93%
1 Year Return
+21.62%
3 Year Return
+290.69%
5 Year Return
+284.46%
10 Year Return
+928.34%
AUM
$1.08B
AUM Growth
+$1.08B
(+53%)
Cap. Flow
+$243M
Cap. Flow
% of AUM
22.47%
Top 10 Holdings %
Top 10 Hldgs %
41.77%
Holding
136
New
30
Increased
24
Reduced
21
Closed
13
Top Buys
Top Sells
| 1 |
EQRX
EQRx, Inc. Common Stock
EQRX
|
$22.4M |
| 2 |
THRD
Third Harmonic Bio
THRD
|
$11.5M |
| 3 |
NovoCure
NVCR
|
$7.95M |
| 4 |
Intellia Therapeutics
NTLA
|
$6.02M |
| 5 |
BioCryst Pharmaceuticals
BCRX
|
$5.99M |
Sector Composition
| 1 | Healthcare | 95.77% |
| 2 | Financials | 3.5% |
| 3 | Real Estate | 0.65% |
| 4 | Technology | 0.08% |
| 5 | Consumer Discretionary | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
126
Galapagos
GLPG
$2.07B
| – | – | -89,650 | Closed | -$3.1M |
|
127
Inspirato
ISPO
$37.4M
| – | – | -875,577 | Closed | -$517K |
|
128
Invivyd
IVVD
$204M
| – | – | -366,536 | Closed | -$623K |
|
|
129
NovoCure
NVCR
$1.38B
| – | – | -492,100 | Closed | -$7.95M |
|
130
TransCode Therapeutics
RNAZ
$8.11M
| – | – | -84,010 | Closed | -$42.2K |
|
|
THRD
131
DELISTED
Third Harmonic Bio
THRD
| – | – | -1,800,000 | Closed | -$11.5M |
|
|
TECX
132
Tectonic Therapeutic, Inc. Common Stock
TECX
$478M
| – | – | -3,512,686 | Closed | -$5.41M |
|
|
NEUP
133
Neuphoria Therapeutics Inc. Common Stock
NEUP
$21.3M
| – | – | -700,000 | Closed | -$1.89M |
|
|
ASLN
134
DELISTED
ASLAN Pharmaceuticals Limited American Depositary Shares
ASLN
| – | – | -1,901,552 | Closed | -$3.57M |
|
|
EQRX
135
DELISTED
EQRx, Inc. Common Stock
EQRX
| – | – | -10,086,110 | Closed | -$22.4M |
|
136
Journey Medical
DERM
$176M
| – | – | -576,100 | Closed | -$1.58M |
|